Sending Office: Honorable Bobby L. Rush
Sent By:

Supporting Organizations: ZERO – The End of Prostate Cancer

Dear Colleague:

Prostate cancer is the second leading cause of cancer death in men in the United States.  For the millions of men who are at-risk of developing this cancer, an early diagnosis of the disease can be the difference between life and
death.  For those diagnosed with early-stage prostate cancer, the survival rate is nearly 100 percent, but it is only 30 percent for late-stage prostate cancer.

African-American men are 70 percent more likely to be diagnosed with prostate cancer disease than white men.  Additionally, men with a father or brother with prostate cancer are more than twice as likely to be diagnosed with prostate
cancer than men without a family history.

That is why we are introducing the Prostate-Specific Antigen Screening for High-risk Insured Men (PSA Screening for HIM) Act.  This bill would waive cost-sharing — including deductibles, copayments, and coinsurances — for prostate
cancer screenings for men who have a family history of prostate cancer or who are African-American.  The removal of these barriers will help millions of at-risk men to diagnose this potentially deadly cancer early.

We invite you to join us in cosponsoring the PSA Screening for HIM Act.  To learn more or to cosponsor, please contact Lauren Citron in Rep. Rush’s office at
or Dylan Moore in Rep. Bucshon’s office at


Bobby L. Rush
Member of Congress

Larry Bucshon
Member of Congress

Related Legislative Issues

Selected legislative information: Family Issues, HealthCare

icon eDC logo e-Dear Colleague version 2.0
e-Dear Colleagues are intended for internal House use only.